Cero Therapeutics Holdings annual current ratio
2021
2022
2023
2024
2025
Cero Therapeutics Holdings Current Ratio Growth & History (CERO)
Cero Therapeutics Holdings's current ratio was 0.30 for fiscal 2025.
View full Cero Therapeutics Holdings company overviewCero Therapeutics Holdings annual current ratio history
| Fiscal year | Period ended | Current ratio | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | 0.30 | −0.20 | −40.03% |
| 2024 | 2024-12-31 | 0.50 | −0.06 | −10.68% |
| 2023 | 2023-12-31 | 0.56 | −0.82 | −59.23% |
| 2022 | 2022-12-31 | 1.38 | −12.50 | −90.07% |
| 2021 | 2021-12-31 | 13.88 | — | — |
Cero Therapeutics Holdings quarterly current ratio
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Current ratio | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | 0.05 | −0.51 | −91.43% |
| Q1 2026 | 2026-03-31 | 0.14 | −0.59 | −81.06% |
| Q4 2025 | 2025-12-31 | 0.30 | −0.20 | −40.03% |
| Q3 2025 | 2025-09-30 | 0.30 | −0.09 | −23.37% |
| Q2 2025 | 2025-06-30 | 0.56 | 0.07 | +15.26% |
| Q1 2025 | 2025-03-31 | 0.73 | 0.26 | +55.44% |
| Q4 2024 | 2024-12-31 | 0.50 | −0.06 | −10.68% |
| Q3 2024 | 2024-09-30 | 0.39 | — | — |
| Q2 2024 | 2024-06-30 | 0.48 | — | — |
| Q1 2024 | 2024-03-31 | 0.47 | — | — |
| Q4 2023 | 2023-12-31 | 0.56 | −0.82 | −59.23% |
| Q4 2022 | 2022-12-31 | 1.38 | −12.50 | −90.07% |
| Q3 2022 | 2022-09-30 | 0.90 | 0.81 | +934.69% |
| Q2 2022 | 2022-06-30 | 3.61 | — | — |
| Q1 2022 | 2022-03-31 | 6.28 | — | — |
| Q4 2021 | 2021-12-31 | 13.88 | — | — |
| Q3 2021 | 2021-09-30 | 0.09 | — | — |
Cero Therapeutics Holdings current ratio trends
Between the periods ended 2021-12-31 and 2025-12-31, Cero Therapeutics Holdings's current ratio decreased from 13.88 to 0.30, a change of −13.58. The latest reported quarter, Q2 2026, shows 0.05.
About the metric
What the current ratio means
The current ratio compares short-term assets with obligations due within roughly one year. A higher ratio generally indicates more short-term balance-sheet coverage, but normal levels vary by industry and business model.
Calculation and source
How the current ratio is calculated
TickerStat calculates the current ratio as SEC-reported current assets divided by SEC-reported current liabilities for the same balance-sheet date. Periods without a positive current-liability value are omitted. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Cero Therapeutics Holdings source filings ↗